Mayo Clinic Platform Standardizes Most cancers Information to Velocity Up Trials
What You Ought to Know
- The Improve: Mayo Clinic Platform_Orchestrate has launched new capabilities that permit researchers to entry standardized, “research-ready” most cancers information.
- The Normal: The platform now makes use of the OMOP Oncology framework, which buildings complicated, messy information (like pathology reviews and tumor staging) right into a constant format that algorithms can simply analyze.
- The Future: Later this yr, Mayo will introduce tokenization, a know-how that connects de-identified affected person information throughout completely different well being methods, giving researchers an entire “longitudinal view” of a most cancers affected person’s journey earlier than, throughout, and after their time at Mayo.
Structuring the Unstructured
The core innovation right here is the mixing of OMOP (Observational Medical Outcomes Partnership) Oncology. This world commonplace permits the platform to ingest unstructured information—like a physician’s handwritten notes or a radiology report—and refine it into structured attributes.
- Inputs: Diagnoses, lab outcomes, imaging, pathology reviews.
- Outputs: Standardized tumor traits, biomarkers, staging, and development information.
“The combination of OMOP Oncology into Mayo Clinic Platform has the ability to speed up discovery, enhance medical trial design, unlock real-world insights and help the event of next-generation therapies for sufferers worldwide,” stated Elisabeth Heath, M.D., chair of the Division of Oncology at Mayo Clinic.
The “Longitudinal” View
Later this yr, the platform will incorporate tokenization. At present, a hospital typically solely sees a affected person when they’re inside its partitions. Tokenization permits de-identified information to be related throughout your entire healthcare ecosystem. This provides researchers a “longitudinal view”—monitoring a affected person’s journey earlier than they arrived at Mayo and after they left. That is important for understanding long-term survivorship and the real-world efficacy of remedies outdoors of a managed trial setting.
Nemesis Health, a analysis and know-how service supplier for Mayo Clinic Platform, contributed to the event of OMOP Oncology capabilities on Orchestrate.
